JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meller, E.
Right arrow Articles by Hiller, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meller, E.
Right arrow Articles by Hiller, J. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*PHENOXYBENZAMINE

Vol. 292, Issue 2, 684-691, February 2000

5-Hydroxytryptamine1A Receptor-Stimulated [35S]GTPgamma S Binding in Rat Brain: Absence of Regional Differences in Coupling Efficiency1

Emanuel Meller, Hua Li, Kenneth D. Carr and Jacob M. Hiller

Millhauser Laboratories, Department of Psychiatry, New York University Medical Center, New York, New York.

In hippocampal membranes, the selective 5-hydroxytryptamine (5-HT1A) receptor agonists 8-hydroxy-dipropylaminotetralin (8-OH-DPAT) and N,N-dipropyl-5-carboxamidotryptamine (N,N-DP-5-CT) stimulated guanosine-5'-O-(3-thio)triphosphate ([35S]GTPgamma S) binding by 130 to 140%; binding stimulated by nonselective agonists (5-HT and 5-CT) was ~30% greater. However, the selective 5-HT1A receptor antagonist N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-2-pyridinyl-cyclohexanecarboxamide (WAY100,635) completely abolished the increases produced by 8-OH-DPAT and N,N-DP-5-CT but only eliminated 70% of that elicited by 5-CT. The rank potency order of the tested agonists was identical with their rank order of affinity for 5-HT1A receptors [5-CT congruent  N,N-DP-5-CT R-(+)-8-OH-DPAT > 5-HT > ipsapirone]. Racemic 8-OH-DPAT and the partial agonist ipsapirone exhibited lower intrinsic activity than R-(+)-8-OH-DPAT. R-(+)-8-OH-DPAT also stimulated [35S]GTPgamma S binding in cortex, but not in striatum, which lacks 5-HT1A receptors. Partial irreversible inactivation of 5-HT1A receptors, in vitro with phenoxybenzamine (0.3 or 1 µM) or in vivo with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (1 mg/kg), reduced the maximal response produced by R-(+)-8-OH-DPAT but did not alter its EC50. In autoradiographic sections, R-(+)-8-OH-DPAT stimulated [35S]GTPgamma S binding in 5-HT1A receptor-rich regions (dorsal hippocampus, 123%; lateral septum, 111%; midhippocampus, 110%; dorsal raphe nucleus, 83%; medial prefrontal cortex, ~60%). The EC50 of R-(+)-8-OH-DPAT did not vary significantly among brain regions (46-96 nM). Partial irreversible blockade of 5-HT1A receptors in brain sections (phenoxybenzamine, 10 µM) reduced the maximal response without altering the EC50 in both the hippocampus and dorsal raphe. Despite prior evidence that dorsal raphe somatodendritic 5-HT1A autoreceptors exhibit high receptor/effector coupling efficiency (receptor reserve) compared with postsynaptic receptors in hippocampus, there was no evidence of a difference at the level of receptor/G protein coupling.


1 This work was supported by U.S. Public Health Service Grant NS 23618.


0022-3565/00/2922-0684$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
P. J. Pauwels and F. C. Colpaert
Ca2+ Responses in Chinese Hamster Ovary-K1 Cells Demonstrate an Atypical Pattern of Ligand-Induced 5-HT1A Receptor Activation
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 608 - 614.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.